drugset / Trial / NCT01175902
Intraocular Pressure and Ocular Perfusion Pressure of Cosopt in Normal Tension Glaucoma
RandomizedCrossoverOpen-labelTreatment
Summary
To prove the non-inferiority of the fixed timolol-dorzolamide combination (Cosopt) compared to 0.005% latanoprost (Xalatan) in the aspects of intraocular pressure (IOP) and ocular perfusion pressure (OPP) in subjects with normal tension glaucoma (NTG) Clinical hypotheses. Primary hypothesis * Cosopt group is non-inferior to Xalatan group in diurnal IOP reduction. Secondary hypothesis * Cosopt group is non-inferior to Xalatan group in diurnal diastolic and systolic OPP.
Timeline
- Start
- 2011-03
- Primary completion
- 2014-10
- Completion
- 2014-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Latanoprost | Small molecule | — | Other |
| Comparator | dorzolamide/timolol | Unknown | — | Other |